PKM and pancreatic ductal adenocarcinoma: Recent studies have demonstrated that PKM2 is highly expressed in multiple cancers, and is closely associated with the disease progression, such as in pancreatic ductal adenocarcinoma (PDAC)20, colorectal cancer21, breast cancer22, and hepatocellular cancer23.